0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

Bleomycin Electrosclerotherapy (BEST) of Slow-Flow Vascular Malformations (SFVMs) in Children

Published: Reading: 1 min

Topic overview

This study evaluates bleomycin electrosclerotherapy (BEST) as a treatment option for slow-flow vascular malformations in pediatric patients, examining safety profiles, clinical effectiveness, and patient-reported outcomes. The research addresses a gap in pediatric evidence for this interventional technique used to manage venous and lymphatic malformations in children.

Key takeaways

  • BEST combines bleomycin with electroporation to treat slow-flow vascular malformations in pediatric patients.
  • Limited pediatric safety and efficacy data exists for BEST, highlighting need for systematic outcome assessment.
  • Study evaluates both clinical effectiveness and patient-reported outcomes to guide treatment decisions.
  • BEST offers alternative to traditional sclerotherapy for challenging slow-flow malformations in children.

Keywords

Vascular Malformations Bleomycin Electrosclerotherapy Pediatric Interventional Radiology Sclerotherapy Slow-flow Malformations Venous Malformations Lymphatic Malformations

Hashtags

#VascularMalformations #PediatricRadiology #InterventionalRadiology #Sclerotherapy

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. Bleomycin Electrosclerotherapy (BEST) of Slow-Flow Vascular Malformations (SFVMs) in Children. GlobalCastMD Medical Library. 2025-09-01. https://library.globalcastmd.com/article/10972

Comments

Loading comments...